APO Research
Talk to an analyst

APO RESEARCH · REPORT

Absorbable Coronary Artery Sirolimus-Eluting Stent System

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025183 pages

Choose your research edition.

Industry ResearchAbsorbable Coronary Artery Sirolimus-Eluting Stent System Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Absorbable Coronary Artery Sirolimus-Eluting Stent System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Absorbable Coronary Artery Sirolimus-Eluting Stent System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Absorbable Coronary Artery Sirolimus-Eluting Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Absorbable Coronary Artery Sirolimus-Eluting Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Absorbable Coronary Artery Sirolimus-Eluting Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Absorbable Coronary Artery Sirolimus-Eluting Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Absorbable Coronary Artery Sirolimus-Eluting Stent System include Wanrui Feihong (Beijing), Shanghai Micro-Invasive Medical Devices, Shandong Huaan Biotechnology, Lepu (Beijing) Medical, Jiwei Medical, Baixinan Bio, QualiMed, Micell Technologies and Kossel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Absorbable Coronary Artery Sirolimus-Eluting Stent System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Absorbable Coronary Artery Sirolimus-Eluting Stent System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Absorbable Coronary Artery Sirolimus-Eluting Stent System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Absorbable Coronary Artery Sirolimus-Eluting Stent System market size, projected growth trends, production technologies, key applications, and end-use industries.

Absorbable Coronary Artery Sirolimus-Eluting Stent System Segment by Company

Wanrui Feihong (Beijing)

Shanghai Micro-Invasive Medical Devices

Shandong Huaan Biotechnology

Lepu (Beijing) Medical

Jiwei Medical

Baixinan Bio

QualiMed

Micell Technologies

Kossel

Absorbable Coronary Artery Sirolimus-Eluting Stent System Segment by Type

Single Coating

Compound Coating

Absorbable Coronary Artery Sirolimus-Eluting Stent System Segment by Application

Hospital

Clinic

Others

Absorbable Coronary Artery Sirolimus-Eluting Stent System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Absorbable Coronary Artery Sirolimus-Eluting Stent System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Absorbable Coronary Artery Sirolimus-Eluting Stent System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Absorbable Coronary Artery Sirolimus-Eluting Stent System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Absorbable Coronary Artery Sirolimus-Eluting Stent System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Absorbable Coronary Artery Sirolimus-Eluting Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Absorbable Coronary Artery Sirolimus-Eluting Stent System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Absorbable Coronary Artery Sirolimus-Eluting Stent System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Trends Table 2. Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Drivers Table 3. Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Opportunities and Challenges Table 4. Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Restraints Table 5. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Manufacturers Table 9. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Manufacturers, Product Type & Application Table 13. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single Coating Table 17. Major Manufacturers of Compound Coating Table 18. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type (2021-2026) & (K Units) Table 20. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type (2027-2032) & (K Units) Table 21. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Type (2021-2026) Table 22. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Type (2027-2032) Table 23. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type (2021-2026) & (K Units) Table 25. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type (2027-2032) & (K Units) Table 26. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Type (2021-2026) Table 27. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application (2021-2026) & (K Units) Table 33. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application (2027-2032) & (K Units) Table 34. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Application (2021-2026) Table 35. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Application (2027-2032) Table 36. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application (2021-2026) & (K Units) Table 38. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application (2027-2032) & (K Units) Table 39. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Application (2021-2026) Table 40. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Application (2027-2032) Table 41. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region (2021-2026) & (K Units) Table 43. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Region (2021-2026) Table 44. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021-2026) & (K Units) Table 48. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2027-2032) & (K Units) Table 49. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021-2026) & (K Units) Table 51. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2027-2032) & (K Units) Table 58. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Region (2021-2026) Table 62. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Region (2027-2032) Table 63. Wanrui Feihong (Beijing) Company Information Table 64. Wanrui Feihong (Beijing) Business Overview Table 65. Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 67. Wanrui Feihong (Beijing) Recent Development Table 68. Shanghai Micro-Invasive Medical Devices Company Information Table 69. Shanghai Micro-Invasive Medical Devices Business Overview Table 70. Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 72. Shanghai Micro-Invasive Medical Devices Recent Development Table 73. Shandong Huaan Biotechnology Company Information Table 74. Shandong Huaan Biotechnology Business Overview Table 75. Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 77. Shandong Huaan Biotechnology Recent Development Table 78. Lepu (Beijing) Medical Company Information Table 79. Lepu (Beijing) Medical Business Overview Table 80. Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 82. Lepu (Beijing) Medical Recent Development Table 83. Jiwei Medical Company Information Table 84. Jiwei Medical Business Overview Table 85. Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 87. Jiwei Medical Recent Development Table 88. Baixinan Bio Company Information Table 89. Baixinan Bio Business Overview Table 90. Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 92. Baixinan Bio Recent Development Table 93. QualiMed Company Information Table 94. QualiMed Business Overview Table 95. QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 97. QualiMed Recent Development Table 98. Micell Technologies Company Information Table 99. Micell Technologies Business Overview Table 100. Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 102. Micell Technologies Recent Development Table 103. Kossel Company Information Table 104. Kossel Business Overview Table 105. Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio Table 107. Kossel Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Absorbable Coronary Artery Sirolimus-Eluting Stent System Distributors List Table 111. Absorbable Coronary Artery Sirolimus-Eluting Stent System Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Image Figure 2. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size (2021-2032) & (US$ Million) Figure 4. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales (2021-2032) & (K Units) Figure 5. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Absorbable Coronary Artery Sirolimus-Eluting Stent System Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single Coating Image Figure 9. Compound Coating Image Figure 10. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Type (2021-2032) Figure 13. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Application (2021-2032) Figure 22. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Application (2021-2032) Figure 25. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Country (2021-2032) Figure 27. U.S. Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Country (2021-2032) Figure 32. Germany Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Country (2021-2032) Figure 39. China Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Country (2021-2032) Figure 47. Brazil Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (2021-2032) & (US$ Million) Figure 58. North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (2021-2032) & (US$ Million) Figure 60. Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Absorbable Coronary Artery Sirolimus-Eluting Stent System Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Absorbable Coronary Artery Sirolimus-Eluting Stent System Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single Coating
  • Compound Coating
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Wanrui Feihong (Beijing)
  • Shanghai Micro-Invasive Medical Devices
  • Shandong Huaan Biotechnology
  • Lepu (Beijing) Medical
  • Jiwei Medical
  • Baixinan Bio
  • QualiMed
  • Micell Technologies
  • Kossel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Dynamics
  1. 2.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Trends
  2. 2.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Drivers
  3. 2.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Opportunities and Challenges
  4. 2.4 Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Restraints
3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market by Manufacturers
  1. 3.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Manufacturers (2021-2026)
  3. 3.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Manufacturers, Product Type & Application
  7. 3.7 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Absorbable Coronary Artery Sirolimus-Eluting Stent System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Absorbable Coronary Artery Sirolimus-Eluting Stent System Tier 1, Tier 2, and Tier 3
4 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market by Type
  1. 4.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Type Introduction
  2. 4.1.1 Single Coating
  3. 4.1.2 Compound Coating
  4. 4.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type
  5. 4.2.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Type (2021-2032)
  7. 4.2.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Type (2021-2032)
  8. 4.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type
  9. 4.3.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Type (2021-2032)
  11. 4.3.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Type (2021-2032)
5 Absorbable Coronary Artery Sirolimus-Eluting Stent System Market by Application
  1. 5.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application
  6. 5.2.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Application (2021-2032)
  8. 5.2.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Market Share by Application (2021-2032)
  9. 5.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application
  10. 5.3.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Application (2021-2032)
  12. 5.3.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Application (2021-2032)
6 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region
  1. 6.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region (2021-2032)
  3. 6.2.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Region (2021-2026)
  4. 6.2.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region
  1. 7.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region
  2. 7.1.1 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (2021-2026)
  4. 7.1.3 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue by Region (2027-2032)
  5. 7.1.4 Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (2021-2032)
  8. 7.2.2 North America Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (2021-2032)
  11. 7.3.2 Europe Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wanrui Feihong (Beijing)
  2. 8.1.1 Wanrui Feihong (Beijing) Company Information
  3. 8.1.2 Wanrui Feihong (Beijing) Business Overview
  4. 8.1.3 Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wanrui Feihong (Beijing) Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  6. 8.1.5 Wanrui Feihong (Beijing) Recent Developments
  7. 8.2 Shanghai Micro-Invasive Medical Devices
  8. 8.2.1 Shanghai Micro-Invasive Medical Devices Company Information
  9. 8.2.2 Shanghai Micro-Invasive Medical Devices Business Overview
  10. 8.2.3 Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Micro-Invasive Medical Devices Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  12. 8.2.5 Shanghai Micro-Invasive Medical Devices Recent Developments
  13. 8.3 Shandong Huaan Biotechnology
  14. 8.3.1 Shandong Huaan Biotechnology Company Information
  15. 8.3.2 Shandong Huaan Biotechnology Business Overview
  16. 8.3.3 Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Huaan Biotechnology Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  18. 8.3.5 Shandong Huaan Biotechnology Recent Developments
  19. 8.4 Lepu (Beijing) Medical
  20. 8.4.1 Lepu (Beijing) Medical Company Information
  21. 8.4.2 Lepu (Beijing) Medical Business Overview
  22. 8.4.3 Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lepu (Beijing) Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  24. 8.4.5 Lepu (Beijing) Medical Recent Developments
  25. 8.5 Jiwei Medical
  26. 8.5.1 Jiwei Medical Company Information
  27. 8.5.2 Jiwei Medical Business Overview
  28. 8.5.3 Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiwei Medical Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  30. 8.5.5 Jiwei Medical Recent Developments
  31. 8.6 Baixinan Bio
  32. 8.6.1 Baixinan Bio Company Information
  33. 8.6.2 Baixinan Bio Business Overview
  34. 8.6.3 Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baixinan Bio Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  36. 8.6.5 Baixinan Bio Recent Developments
  37. 8.7 QualiMed
  38. 8.7.1 QualiMed Company Information
  39. 8.7.2 QualiMed Business Overview
  40. 8.7.3 QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 QualiMed Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  42. 8.7.5 QualiMed Recent Developments
  43. 8.8 Micell Technologies
  44. 8.8.1 Micell Technologies Company Information
  45. 8.8.2 Micell Technologies Business Overview
  46. 8.8.3 Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Micell Technologies Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  48. 8.8.5 Micell Technologies Recent Developments
  49. 8.9 Kossel
  50. 8.9.1 Kossel Company Information
  51. 8.9.2 Kossel Business Overview
  52. 8.9.3 Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kossel Absorbable Coronary Artery Sirolimus-Eluting Stent System Product Portfolio
  54. 8.9.5 Kossel Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Value Chain Analysis
  2. 9.1.1 Absorbable Coronary Artery Sirolimus-Eluting Stent System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Absorbable Coronary Artery Sirolimus-Eluting Stent System Production Mode & Process
  6. 9.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Absorbable Coronary Artery Sirolimus-Eluting Stent System Distributors
  9. 9.2.3 Absorbable Coronary Artery Sirolimus-Eluting Stent System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst